vs

Side-by-side financial comparison of Dynatrace, Inc. (DT) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $515.5M, roughly 2.0× Dynatrace, Inc.). Dynatrace, Inc. runs the higher net margin — 7.8% vs 5.5%, a 2.3% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 18.2%). Dynatrace, Inc. produced more free cash flow last quarter ($27.2M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 16.3%).

Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.

DT vs ECG — Head-to-Head

Bigger by revenue
ECG
ECG
2.0× larger
ECG
$1.0B
$515.5M
DT
Growing faster (revenue YoY)
ECG
ECG
+15.0% gap
ECG
33.2%
18.2%
DT
Higher net margin
DT
DT
2.3% more per $
DT
7.8%
5.5%
ECG
More free cash flow
DT
DT
$3.7M more FCF
DT
$27.2M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
16.3%
DT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DT
DT
ECG
ECG
Revenue
$515.5M
$1.0B
Net Profit
$40.1M
$55.3M
Gross Margin
81.4%
11.6%
Operating Margin
14.1%
6.8%
Net Margin
7.8%
5.5%
Revenue YoY
18.2%
33.2%
Net Profit YoY
-88.9%
60.4%
EPS (diluted)
$0.13
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DT
DT
ECG
ECG
Q4 25
$515.5M
$1.0B
Q3 25
$493.8M
$986.8M
Q2 25
$477.3M
$921.5M
Q1 25
$445.2M
$826.6M
Q4 24
$436.2M
$759.6M
Q3 24
$418.1M
$761.0M
Q2 24
$399.2M
$703.4M
Q1 24
$380.8M
$625.7M
Net Profit
DT
DT
ECG
ECG
Q4 25
$40.1M
$55.3M
Q3 25
$57.2M
$57.0M
Q2 25
$48.0M
$52.8M
Q1 25
$39.3M
$36.7M
Q4 24
$361.8M
$34.5M
Q3 24
$44.0M
$41.8M
Q2 24
$38.6M
$39.0M
Q1 24
$37.9M
$28.2M
Gross Margin
DT
DT
ECG
ECG
Q4 25
81.4%
11.6%
Q3 25
81.8%
12.6%
Q2 25
82.1%
13.0%
Q1 25
80.9%
11.2%
Q4 24
81.1%
11.4%
Q3 24
81.4%
11.8%
Q2 24
81.3%
12.6%
Q1 24
81.1%
11.9%
Operating Margin
DT
DT
ECG
ECG
Q4 25
14.1%
6.8%
Q3 25
14.8%
7.3%
Q2 25
13.1%
7.9%
Q1 25
9.6%
6.2%
Q4 24
10.9%
6.1%
Q3 24
11.2%
7.1%
Q2 24
10.5%
7.3%
Q1 24
6.1%
6.2%
Net Margin
DT
DT
ECG
ECG
Q4 25
7.8%
5.5%
Q3 25
11.6%
5.8%
Q2 25
10.0%
5.7%
Q1 25
8.8%
4.4%
Q4 24
82.9%
4.5%
Q3 24
10.5%
5.5%
Q2 24
9.7%
5.5%
Q1 24
10.0%
4.5%
EPS (diluted)
DT
DT
ECG
ECG
Q4 25
$0.13
$1.09
Q3 25
$0.19
$1.11
Q2 25
$0.16
$1.03
Q1 25
$0.12
$0.72
Q4 24
$1.19
$0.68
Q3 24
$0.15
$0.82
Q2 24
$0.13
$0.76
Q1 24
$0.13
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DT
DT
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$1.2B
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$2.7B
$629.8M
Total Assets
$4.1B
$1.7B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DT
DT
ECG
ECG
Q4 25
$1.2B
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.0B
$553.0K
Q2 24
$1.0B
Q1 24
$836.9M
Total Debt
DT
DT
ECG
ECG
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DT
DT
ECG
ECG
Q4 25
$2.7B
$629.8M
Q3 25
$2.8B
$573.0M
Q2 25
$2.7B
$514.4M
Q1 25
$2.6B
$460.2M
Q4 24
$2.6B
$422.6M
Q3 24
$2.1B
$453.3M
Q2 24
$2.1B
$490.0M
Q1 24
$2.0B
$464.3M
Total Assets
DT
DT
ECG
ECG
Q4 25
$4.1B
$1.7B
Q3 25
$4.1B
$1.6B
Q2 25
$4.1B
$1.5B
Q1 25
$4.1B
$1.4B
Q4 24
$3.7B
$1.3B
Q3 24
$3.3B
$1.3B
Q2 24
$3.3B
Q1 24
$3.4B
Debt / Equity
DT
DT
ECG
ECG
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DT
DT
ECG
ECG
Operating Cash FlowLast quarter
$33.8M
$48.2M
Free Cash FlowOCF − Capex
$27.2M
$23.5M
FCF MarginFCF / Revenue
5.3%
2.3%
Capex IntensityCapex / Revenue
1.3%
2.4%
Cash ConversionOCF / Net Profit
0.84×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$465.5M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DT
DT
ECG
ECG
Q4 25
$33.8M
$48.2M
Q3 25
$32.0M
$76.2M
Q2 25
$269.7M
$25.3M
Q1 25
$162.8M
$7.1M
Q4 24
$42.2M
Q3 24
$23.6M
$78.9M
Q2 24
$230.7M
Q1 24
$131.7M
$21.9M
Free Cash Flow
DT
DT
ECG
ECG
Q4 25
$27.2M
$23.5M
Q3 25
$27.8M
$65.7M
Q2 25
$262.2M
$12.3M
Q1 25
$148.2M
$-11.4M
Q4 24
$37.6M
Q3 24
$20.1M
$60.9M
Q2 24
$227.4M
Q1 24
$121.9M
$12.6M
FCF Margin
DT
DT
ECG
ECG
Q4 25
5.3%
2.3%
Q3 25
5.6%
6.7%
Q2 25
54.9%
1.3%
Q1 25
33.3%
-1.4%
Q4 24
8.6%
Q3 24
4.8%
8.0%
Q2 24
57.0%
Q1 24
32.0%
2.0%
Capex Intensity
DT
DT
ECG
ECG
Q4 25
1.3%
2.4%
Q3 25
0.8%
1.1%
Q2 25
1.6%
1.4%
Q1 25
3.3%
2.2%
Q4 24
1.1%
Q3 24
0.8%
2.4%
Q2 24
0.8%
Q1 24
2.6%
1.5%
Cash Conversion
DT
DT
ECG
ECG
Q4 25
0.84×
0.87×
Q3 25
0.56×
1.34×
Q2 25
5.62×
0.48×
Q1 25
4.14×
0.19×
Q4 24
0.12×
Q3 24
0.54×
1.89×
Q2 24
5.97×
Q1 24
3.47×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DT
DT

Subscription And Circulation$493.4M96%
Services$22.1M4%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons